Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Nov 2021
Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
While Prostate Imaging Reporting and Data System (PI-RADS) 4 and 5 lesions typically warrant prostate biopsy and PI-RADS 1 and 2 lesions may be safely observed, PI-RADS 3 lesions are equivocal. ⋯ 4 TECHNICAL EFFICACY: 2.
-
J Magn Reson Imaging · Nov 2021
Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomic Model for Discrimination of Pathological Subtypes of Craniopharyngioma.
Preoperative, noninvasive discrimination of the craniopharyngioma subtypes is important because it influences the treatment strategy. ⋯ 4 TECHNICAL EFFICACY: 2.
-
J Magn Reson Imaging · Nov 2021
Randomized Controlled TrialAssociation Between T2 * Relaxation Times Derived From Ultrashort Echo Time MRI and Symptoms During Exercise Therapy for Patellar Tendinopathy: A Large Prospective Study.
Exercise therapy is considered preferential treatment for patellar tendinopathy (PT). However, there is conflicting evidence for structural patellar tendon adaptation in response to exercise therapy and its association with symptoms is weak. ⋯ 1 TECHNICAL EFFICACY: Stage 4.
-
J Magn Reson Imaging · Oct 2021
Randomized Controlled TrialRadiomics Nomograms Based on Non-enhanced MRI and Clinical Risk Factors for the Differentiation of Chondrosarcoma from Enchondroma.
Differentiating chondrosarcoma from enchondroma using conventional MRI remains challenging. An effective method for accurate preoperative diagnosis could affect the management and prognosis of patients. ⋯ 4 TECHNICAL EFFICACY: Stage 2.
-
J Magn Reson Imaging · Oct 2021
Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods.
Radiomics has shown promising results in the diagnosis, efficacy, and prognostic assessments of multiple myeloma (MM). However, little evidence exists on the utility of radiomics in predicting a high-risk cytogenetic (HRC) status in MM. ⋯ 3 TECHNICAL EFFICACY: Stage 2.